Skip to content

Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool

Initial Assessment of the Validity and Inter-Rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06381999
Acronym
I-REFER
Enrollment
70
Registered
2024-04-24
Start date
2023-10-27
Completion date
2024-02-26
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Spasticity

Brief summary

The aim of this study is to investigate the validity and Inter-rater reliability for early recognition of spasticity by nurses and physiotherapists using the decision tree tool.

Detailed description

The Spastic Movement Disorder (SMD) Decision Tree was designed as a tool to aid nurses, therapists and other healthcare professions recognize potential signs of disabling spasticity in the upper limb of post-stroke patients. The present study assesses validity and inter-rater reliability of the SMD Decision Tree comparing nurses and therapists with gold-standard procedure performed by rehabilitation doctors. Agreement was tested for "referral to specialist indicated" and "no referral to specialist indicated".

Interventions

None listed

Sponsors

Merz Therapeutics GmbH
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Participants with a first sub-acute and chronic infarction of the middle cerebral artery / basal ganglia hemorrhage longer than four weeks after the event * Between 18-80 years old * Preserved insight and judgment capacity * Adequate language and task comprehension, attention span for 15 minutes

Exclusion criteria

* Participants with other neurological disorders * Participants who received BoNT-A treatment \< 3 months before inclusion * Reduced vigilance and attention span (less than 15 minutes) * Participants with adult representation * Participants with severe language impairment / impairment of movement and action sequences

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the level of agreement between the nurse group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referralDay 1-2Nurses use the 3 domains of the SMD Decision Tree (passive/active movement, pain) to determine potential disabling spasticity indicated for referral to a rehabilitation specialist. Specialized physicians use standard clinical procedure to detect disabling spasticity.

Secondary

MeasureTime frame
Assessment of the level of agreement between the physiotherapist and/or occupational therapist group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referralDay 1-2

Countries

Austria

Contacts

STUDY_DIRECTORMerz Medical Expert

Merz Therapeutics

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026